Tech Company Financing Transactions

Glox Therapeutics Funding Round

Boehringer Ingelheim Venture Fund and Scottish Enterprise participated in a $5.4 million Seed funding round for Glox Therapeutics. The round was announced on 11/14/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

11 The Square University Of Glasgow University Avenue
Glasgow, Scotland, G12 8QQ
UK

Phone

Undisclosed

Website

www.gloxtherapeutics.com

Email Address

[email protected]

Overview

Glox Therapeutics was founded by Professor Daniel Walker, Professor Colin Kleanthous and Dr James Clark in February 2023 to exploit recent advances in understanding bacteriocin structure and mode of action made in the laboratories of Professors Walker and Kleanthous at the University of Glasgow and University of Oxford, respectively.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

James Clark

        

Chief Scientific Officer

Daniel Walker

        

Browse more venture capital transactions:

Prev: 11/14/2023: Radiant Security venture capital transaction
Next: 11/14/2023: Augmentus venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary